Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Total article views   HTML views PDF downloads Totals
16,049 Dovepress* 10,012+ 2,287 12,299
PubMed Central* 6,037 657 6,694
Totals 16,049 2,944 18,993
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar